E.S. Makashova
Burdenko Neurosurgical Center;
Loginov Moscow Clinical Research Practical Center
M.V. Galkin
Burdenko National Medical Research Center for Neurosurgery
A.V. Kozlov
Burdenko Neurosurgical Center;
Andijan State Medical Institute
A.V. Golanov
Burdenko Neurosurgical Center;
Russian Medical Academy of Continuous Professional Education
New classification and approaches to the treatment of schwannomatosis
Journal: Burdenko's Journal of Neurosurgery. 2023;87(5): 104‑109
Views: 2419
Downloaded: 18
To cite this article:
Makashova ES, Zolotova SV, Absalyamova OV, Galkin MV, Petrokovskaya AV, Kozlov AV, Golanov AV. New classification and approaches to the treatment of schwannomatosis. Burdenko's Journal of Neurosurgery.
2023;87(5):104‑109. (In Russ., In Engl.)
https://doi.org/10.17116/neiro202387051104
Schwannomatoses is a new classification unit for all the hereditary diseases caused by chromosome 22 damage followed by multiple benign neoplasms of the peripheral and central nervous system. Schwannomatosis occurs as a result of damage to different genes: NF2, SMARCB1, LZRT1, loss of heterozygosity of the long arm of chromosome 22. Nevertheless, clinical manifestations are similar. Molecular diagnostics not only confirms the diagnosis, but also predicts the course of disease. Thus, the most severe clinical manifestations are observed in patients with violation of semantic sequences and reading frame shift in exons 2—13 of the NF2 gene. A more favorable course with less number of tumors is observed in patients with somatic mosaicism. Stereotactic irradiation and surgery are the main treatment options for schwannomatosis. However, there is evidence of effective targeted therapy with bevacizumab (inhibitor of vascular endothelial growth factor). Bevacizumab is used in patients with bilateral vestibular schwannomas and high risk of hearing loss, as well as for intramedullary tumor growth control.
Authors:
E.S. Makashova
Burdenko Neurosurgical Center;
Loginov Moscow Clinical Research Practical Center
M.V. Galkin
Burdenko National Medical Research Center for Neurosurgery
A.V. Kozlov
Burdenko Neurosurgical Center;
Andijan State Medical Institute
A.V. Golanov
Burdenko Neurosurgical Center;
Russian Medical Academy of Continuous Professional Education
Received:
01.12.2022
Accepted:
13.07.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.